The FDA just approved Toujeo a once-daily long-acting basal insulin, to improve glycemic control in adults living with type 1 and type 2 diabetes. Toujeo is injected once a day under the skin.
Toujeo is designed to to release insulin more gradually therefore can regulate blood sugars more consistently throughout the day.
For more information on this medication, visit [ Ссылка ]
